With pharmaceutical companies increasingly deploying AI in direct-to-consumer platforms, the regulatory landscape remains fragmented. In the absence of comprehensive federal action, states are stepping in with disparate laws to address privacy and safety concerns, creating a complex compliance challenge for the industry.
Quince Therapeutics' lead candidate, eDSP, has failed to meet primary and secondary endpoints in its pivotal Phase III NEAT trial for the rare neurological disorder Ataxia-Telangiectasia (A-T), triggering a catastrophic drop in the company's share price.
A new federal loan aims to help the revived Buell Motorcycle Company scale production of its high-performance Super Cruiser, testing whether niche innovation can find a sustainable path in a competitive market.
In Zimbabwe, where formal employment is scarce and medical costs are prohibitive, a stark financial choice is being made: affordable funeral policies are vastly outpacing health insurance, reflecting a cultural prioritization of dignified burials over accessible healthcare.
A U.S. federal judge has ordered the release of an Ecuadorian asylum-seeking father and his young son, detained in a Minnesota ICE operation, delivering a scathing critique of the administration's immigration enforcement tactics.
Amid a contentious federal immigration operation, Minneapolis residents report heightened tensions and an increased security presence, contradicting official promises of de-escalation. The arrests of journalists and unresolved fatal shootings have intensified scrutiny and community-led resistance.
While robust cash generation is a hallmark of financial health, it doesn't guarantee stock outperformance. We examine three companies—PVH, Scorpio Tankers, and Amneal Pharmaceuticals—where strong cash flows are overshadowed by strategic challenges, raising red flags for discerning investors.
Initial drill results from the Senneville gold-silver-copper property in Quebec's prolific Val-d'Or camp have intersected significant near-surface mineralization, with intervals up to 57.8 meters, marking a promising start to the multi-phase exploration campaign.
Cogent Biosciences secures a key FDA Breakthrough Therapy Designation for its bezuclastinib-sunitinib combination in advanced GIST, following promising Phase 3 data that showed a halving of disease progression risk.
Erasca (ERAS) gains significant analyst momentum as Mizuho initiates coverage with an 'Outperform' rating and a $16 price target, citing confidence in its 2026 proof-of-concept milestones for RAS-targeted cancer therapies.
Recent data shows the average Bitcoin held by U.S. spot ETFs is now worth less than its purchase price, following two consecutive weeks of major outflows that have deepened the cryptocurrency's downturn.
Takeda Pharmaceutical raises its FY2025 revenue and profit guidance following resilient nine-month results and announces U.S. availability of a new ready-to-use immunoglobulin therapy for primary immunodeficiency, fueling discussions on its growth strategy amid high debt and margin pressures.
After years of relentless growth, a cooling trend is taking hold in several Western U.S. housing markets. We examine the metros where prices are falling, what's driving the change, and how prospective buyers can navigate this shifting landscape.
Tyson Foods' recent quarterly performance, marked by strength in chicken and prepared foods, is being scrutinized as rising beef input costs pressure margins. The stock's pre-earnings surge sets a high bar for the company to prove its operational turnaround can deliver sustainable profits.
Russia's former president Dmitry Medvedev cautions that the potential lapse of the last major U.S.-Russia nuclear arms treaty without a successor could plunge the world into an unprecedented era of strategic instability unseen since the Cold War.
Travere Therapeutics faces a securities fraud investigation by Robbins Geller Rudman & Dowd LLP, raising questions about the accuracy of its past disclosures. The probe casts a shadow over the company's critical transition, as it banks on its kidney drug FILSPARI to drive growth amid mounting legal and commercial pressures.
Backed by a major U.S. government loan and a surge in private equity, USA Rare Earth is accelerating its domestic mining and manufacturing projects, positioning itself at the forefront of a critical national strategy.
ProPublica has identified the two Customs and Border Protection officers who discharged their weapons during an encounter that resulted in the death of Alex Pretti, a 37-year-old nurse. The incident has intensified scrutiny of federal immigration enforcement tactics in urban areas.
A confluence of geopolitical tensions and macroeconomic pressures sparked a broad crypto market rout over the weekend, creating one of Bitcoin's largest CME futures gaps on record and wiping out over $5.4 billion in leveraged positions.
A recent wave of deadly attacks in Pakistan's Balochistan province, claimed by the banned Baloch Liberation Army (BLA), has spotlighted the escalating capabilities and ambitions of a group that threatens regional stability and critical Chinese investments.
